Menu
← Oncology Approval Tracker
FDA DECISION ·
Albumin-bound paclitaxel (Teva)
paclitaxel protein-bound particles · Teva Pharmaceuticals
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
A 100 mg vial of albumin-bound paclitaxel for labeled previously treated breast cancer, first-line advanced NSCLC with carboplatin, and first-line metastatic pancreatic adenocarcinoma with gemcitabine.
LAMPGEN ANALYSIS
Why it matters
The NDA added a product-specific albumin-bound formulation for multiple established regimens.
What research teams should watch
Verify the albumin-bound formulation, reconstitution and the combination partner appropriate to the indication.
PRIMARY RECORDS